vs

Side-by-side financial comparison of PATHWARD FINANCIAL, INC. (CASH) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

PATHWARD FINANCIAL, INC. is the larger business by last-quarter revenue ($173.1M vs $164.7M, roughly 1.1× PTC THERAPEUTICS, INC.). PATHWARD FINANCIAL, INC. runs the higher net margin — 20.3% vs -82.0%, a 102.3% gap on every dollar of revenue. On growth, PATHWARD FINANCIAL, INC. posted the faster year-over-year revenue change (-0.2% vs -22.7%). PATHWARD FINANCIAL, INC. produced more free cash flow last quarter ($104.1M vs $-36.6M). Over the past eight quarters, PTC THERAPEUTICS, INC.'s revenue compounded faster (-11.5% CAGR vs -18.0%).

Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

CASH vs PTCT — Head-to-Head

Bigger by revenue
CASH
CASH
1.1× larger
CASH
$173.1M
$164.7M
PTCT
Growing faster (revenue YoY)
CASH
CASH
+22.5% gap
CASH
-0.2%
-22.7%
PTCT
Higher net margin
CASH
CASH
102.3% more per $
CASH
20.3%
-82.0%
PTCT
More free cash flow
CASH
CASH
$140.7M more FCF
CASH
$104.1M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
PTCT
PTCT
Annualised
PTCT
-11.5%
-18.0%
CASH

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CASH
CASH
PTCT
PTCT
Revenue
$173.1M
$164.7M
Net Profit
$35.2M
$-135.0M
Gross Margin
Operating Margin
24.6%
-43.3%
Net Margin
20.3%
-82.0%
Revenue YoY
-0.2%
-22.7%
Net Profit YoY
11.9%
-104.8%
EPS (diluted)
$1.57
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CASH
CASH
PTCT
PTCT
Q4 25
$173.1M
$164.7M
Q3 25
$186.7M
$211.0M
Q2 25
$195.8M
$178.9M
Q1 25
$274.8M
$1.2B
Q4 24
$182.6M
$213.2M
Q3 24
$179.5M
$196.8M
Q2 24
$188.6M
$186.7M
Q1 24
$257.6M
$210.1M
Net Profit
CASH
CASH
PTCT
PTCT
Q4 25
$35.2M
$-135.0M
Q3 25
$38.8M
$15.9M
Q2 25
$42.1M
$-64.8M
Q1 25
$75.0M
$866.6M
Q4 24
$30.0M
$-65.9M
Q3 24
$33.5M
$-106.7M
Q2 24
$44.9M
$-99.2M
Q1 24
$69.9M
$-91.6M
Operating Margin
CASH
CASH
PTCT
PTCT
Q4 25
24.6%
-43.3%
Q3 25
25.9%
1.4%
Q2 25
24.1%
-19.5%
Q1 25
33.2%
82.5%
Q4 24
19.8%
-76.2%
Q3 24
20.9%
-27.7%
Q2 24
27.1%
-21.5%
Q1 24
33.8%
-21.6%
Net Margin
CASH
CASH
PTCT
PTCT
Q4 25
20.3%
-82.0%
Q3 25
20.8%
7.5%
Q2 25
21.5%
-36.3%
Q1 25
27.3%
73.7%
Q4 24
16.4%
-30.9%
Q3 24
18.7%
-54.2%
Q2 24
23.8%
-53.1%
Q1 24
27.1%
-43.6%
EPS (diluted)
CASH
CASH
PTCT
PTCT
Q4 25
$1.57
$-1.63
Q3 25
$1.69
$0.20
Q2 25
$1.81
$-0.83
Q1 25
$3.14
$10.04
Q4 24
$1.23
$-0.85
Q3 24
$1.34
$-1.39
Q2 24
$1.78
$-1.29
Q1 24
$2.74
$-1.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CASH
CASH
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$331.2M
$1.9B
Total DebtLower is stronger
$33.5M
Stockholders' EquityBook value
$854.5M
$-205.3M
Total Assets
$7.6B
$2.9B
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CASH
CASH
PTCT
PTCT
Q4 25
$331.2M
$1.9B
Q3 25
$120.6M
$1.7B
Q2 25
$258.3M
$2.0B
Q1 25
$254.2M
$2.0B
Q4 24
$597.4M
$1.1B
Q3 24
$158.3M
$1.0B
Q2 24
$298.9M
$1.1B
Q1 24
$347.9M
$884.8M
Total Debt
CASH
CASH
PTCT
PTCT
Q4 25
$33.5M
Q3 25
$33.5M
Q2 25
$33.4M
Q1 25
$33.4M
Q4 24
$33.4M
Q3 24
$33.4M
Q2 24
$33.3M
Q1 24
$33.4M
Stockholders' Equity
CASH
CASH
PTCT
PTCT
Q4 25
$854.5M
$-205.3M
Q3 25
$858.0M
$-155.8M
Q2 25
$819.0M
$-206.5M
Q1 25
$814.7M
$-185.8M
Q4 24
$758.3M
$-1.1B
Q3 24
$822.5M
$-1.1B
Q2 24
$748.4M
$-980.2M
Q1 24
$719.5M
$-893.9M
Total Assets
CASH
CASH
PTCT
PTCT
Q4 25
$7.6B
$2.9B
Q3 25
$7.2B
$2.6B
Q2 25
$7.2B
$2.6B
Q1 25
$7.0B
$2.7B
Q4 24
$7.6B
$1.7B
Q3 24
$7.5B
$1.8B
Q2 24
$7.5B
$1.9B
Q1 24
$7.4B
$1.8B
Debt / Equity
CASH
CASH
PTCT
PTCT
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.04×
Q2 24
0.04×
Q1 24
0.05×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CASH
CASH
PTCT
PTCT
Operating Cash FlowLast quarter
$108.3M
$-34.3M
Free Cash FlowOCF − Capex
$104.1M
$-36.6M
FCF MarginFCF / Revenue
60.1%
-22.3%
Capex IntensityCapex / Revenue
2.4%
1.4%
Cash ConversionOCF / Net Profit
3.08×
TTM Free Cash FlowTrailing 4 quarters
$616.8M
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CASH
CASH
PTCT
PTCT
Q4 25
$108.3M
$-34.3M
Q3 25
$303.7M
$-66.3M
Q2 25
$30.4M
$-58.3M
Q1 25
$188.3M
$870.1M
Q4 24
$-71.7M
$-30.0M
Q3 24
$143.1M
$-77.0M
Q2 24
$113.2M
$-71.5M
Q1 24
$203.0M
$70.8M
Free Cash Flow
CASH
CASH
PTCT
PTCT
Q4 25
$104.1M
$-36.6M
Q3 25
$300.3M
$-69.7M
Q2 25
$27.7M
$-59.6M
Q1 25
$184.7M
$868.4M
Q4 24
$-73.8M
$-33.8M
Q3 24
$138.8M
$-77.5M
Q2 24
$111.0M
$-78.8M
Q1 24
$201.3M
$61.2M
FCF Margin
CASH
CASH
PTCT
PTCT
Q4 25
60.1%
-22.3%
Q3 25
160.9%
-33.1%
Q2 25
14.1%
-33.3%
Q1 25
67.2%
73.8%
Q4 24
-40.4%
-15.8%
Q3 24
77.3%
-39.4%
Q2 24
58.8%
-42.2%
Q1 24
78.1%
29.1%
Capex Intensity
CASH
CASH
PTCT
PTCT
Q4 25
2.4%
1.4%
Q3 25
1.8%
1.6%
Q2 25
1.4%
0.7%
Q1 25
1.3%
0.1%
Q4 24
1.1%
1.8%
Q3 24
2.4%
0.3%
Q2 24
1.2%
4.0%
Q1 24
0.7%
4.6%
Cash Conversion
CASH
CASH
PTCT
PTCT
Q4 25
3.08×
Q3 25
7.83×
-4.17×
Q2 25
0.72×
Q1 25
2.51×
1.00×
Q4 24
-2.39×
Q3 24
4.27×
Q2 24
2.52×
Q1 24
2.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CASH
CASH

Consumer$103.0M59%
Payment Card And Deposit Fees$30.1M17%
Other$24.2M14%
Rental Income$11.6M7%
Commercial$4.2M2%

PTCT
PTCT

Segment breakdown not available.

Related Comparisons